Jeff Wolf
Algemeen Directeur bij SCORPIUS HOLDINGS, INC.
Vermogen: 670 732 $ op 30-04-2024
Profiel
Jeff A.
Wolf was the founder of TYRX, Inc. (founded in 1998) and Scorpius Holdings, Inc. (founded in 2008) where he held the title of Chairman.
He is also the founder of Pelican Therapeutics, Inc. (founded in 2017) where he is currently a Director.
Additionally, Mr. Wolf founded Seed-One Ventures LLC (founded in 1997) where he served as the Managing Director from 1997 to 2011.
Mr. Wolf was also the founder of Sensatex, Inc., Generation Mobile, Inc., Avigen, Inc., Elusys Therapeutics, Inc., GenerationOne, Inc., and Scorpius BioManufacturing, Inc.Mr. Wolf's current job was as an Independent Director at Theriva Biologics, Inc. since 2006.
Mr. Wolf's former jobs include being a Director at Netli, Inc., a Managing Director at Castle Group Ltd., and a Managing Director at Sunrock Equity Partners LLC.
Mr. Wolf's education history includes an undergraduate degree from The University of Chicago, an MBA from Stanford Graduate School of Business, and a graduate degree from New York University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SCORPIUS HOLDINGS, INC.
11.42% | 16-05-2024 | 4 114 922 ( 11.42% ) | 670 732 $ | 30-04-2024 |
THERIVA BIOLOGICS, INC.
-.--% | 25-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Jeff Wolf
| Bedrijven | Functie | Begin |
|---|---|---|
| THERIVA BIOLOGICS, INC. | Directeur/Bestuurslid | 01-01-2006 |
| SCORPIUS HOLDINGS, INC. | Algemeen Directeur | 01-04-2010 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Algemeen Directeur | - |
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Oprichter | 06-03-2017 |
Scorpius BioManufacturing, Inc.
 Scorpius BioManufacturing, Inc. BiotechnologyHealth Technology Part of NightHawk Biosciences, Inc., Scorpius BioManufacturing, Inc. is a contract research and manufacturing organization focused on cell- and gene-based therapies and large molecule biologics. The company is based in San Antonio, TX. The company provides clinical-scale biomanufacturing, analytical, and R&D services to pharmaceutical and biotech companies from its facilities in Texas. Scorpius plans to offer commercial-scale biomanufacturing from its newly announced site. The company was founded by Jeff A. Wolf, and Stephan Kutzer has been the CEO of the company since 2022. | Oprichter | - |
Eerdere bekende functies van Jeff Wolf
| Bedrijven | Functie | Einde |
|---|---|---|
Seed-One Ventures LLC
 Seed-One Ventures LLC Investment ManagersFinance Seed-One Ventures (Seed-One) is a venture capital firm founded in 1997 by Jeff Wolf. The firm is headquartered in Durham, North Carolina. | Oprichter | 01-03-2011 |
Netli, Inc.
 Netli, Inc. Information Technology ServicesTechnology Services Netli, Inc. provides Internet infrastructure services. Its products include netlilightning, netlioffload, netliview, and netlicontinuity. The company was founded in 1999 by Adam J. Grove & Michael Kharitonov and is headquartered in Palo Alto, CA | Directeur/Bestuurslid | 23-02-2011 |
TYRX, Inc.
 TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Oprichter | - |
| Sensatex, Inc. | Oprichter | - |
| ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Opleiding van Jeff Wolf
| The University of Chicago | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| THERIVA BIOLOGICS, INC. | Health Technology |
| SCORPIUS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 12 |
|---|---|
Sunrock Equity Partners LLC
 Sunrock Equity Partners LLC Investment ManagersFinance Founded in 2007 by Jeffrey Wolf and Matthew Shaw, Sunrock Equity Partners LLC is a venture capital firm located in Miami Beach, Florida with an additional office in Tampa, Florida | Finance |
TYRX, Inc.
TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Technology |
Seed-One Ventures LLC
Seed-One Ventures LLC Investment ManagersFinance Seed-One Ventures (Seed-One) is a venture capital firm founded in 1997 by Jeff Wolf. The firm is headquartered in Durham, North Carolina. | Finance |
| Sensatex, Inc. | |
Castle Group Ltd.
 Castle Group Ltd. Real Estate DevelopmentFinance Part of Places for People Group Ltd., Castle Group Ltd. is a holding British company with interests in residential property management and portable appliance testing. The company is based in Scarborough, UK. Castle Group was acquired by Paladin Group Ltd. on July 14, 2006 for $14.74 million. | Finance |
Netli, Inc.
Netli, Inc. Information Technology ServicesTechnology Services Netli, Inc. provides Internet infrastructure services. Its products include netlilightning, netlioffload, netliview, and netlicontinuity. The company was founded in 1999 by Adam J. Grove & Michael Kharitonov and is headquartered in Palo Alto, CA | Technology Services |
Generation Mobile, Inc.
 Generation Mobile, Inc. Miscellaneous Commercial ServicesCommercial Services Generation Mobile, Inc. operates as an IT consulting office. The private company is based in San Francisco, CA. The company was founded by Jeff A. Wolf. | Commercial Services |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
GenerationOne, Inc.
 GenerationOne, Inc. Miscellaneous Commercial ServicesCommercial Services GenerationOne, Inc. develops mobile health application program to manage health and wellness. Its application mHealth Connect, can support unlimited care paths, including chronic care and wellness initiatives. It provides services to professionals, organization, and with health concern individual. The company was founded in 1997 and is headquartered in Southfield, MI. | Commercial Services |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Scorpius BioManufacturing, Inc.
Scorpius BioManufacturing, Inc. BiotechnologyHealth Technology Part of NightHawk Biosciences, Inc., Scorpius BioManufacturing, Inc. is a contract research and manufacturing organization focused on cell- and gene-based therapies and large molecule biologics. The company is based in San Antonio, TX. The company provides clinical-scale biomanufacturing, analytical, and R&D services to pharmaceutical and biotech companies from its facilities in Texas. Scorpius plans to offer commercial-scale biomanufacturing from its newly announced site. The company was founded by Jeff A. Wolf, and Stephan Kutzer has been the CEO of the company since 2022. | Health Technology |